Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
- PMID: 24966506
- PMCID: PMC4061344
- DOI: 10.1007/s13224-014-0515-6
Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
Abstract
Objective: To evaluate role of serum estradiol levels in predicting likelihood of pregnancy in women undergoing GnRH-a protocol in IVF-ET cycles.
Design: A 3-year retrospective analysis of estradiol levels on down-regulated day 2, day 6, and day of hCG trigger and subsequent clinical pregnancy rates.
Setting: A university hospital tertiary referral centre.
Population or sample: Women undergoing IVF treatment.
Methods: Hormonal assessment on the down-regulated day 2, day 6, and day of hCG trigger.
Main outcome measures: Comparison of hormonal profile, antral follicular count on day 2, endometrial thickness on day of trigger, and number of oocytes retrieved between pregnant and the non-pregnant group. The prediction of IVF success was based on the quantitative levels of estradiol on a specific day in down-regulated cycle.
Results: The overall pregnancy rate was 32.25 % (50/160). Estradiol level on down-regulated day 2 was 31.9 ± 12.6 and on the day of trigger was 1,996.46 ± 1,252.36 in pregnant women, which was significantly higher as compared to estradiol levels in non-pregnant women (27.6 ± 12.3 and 1,525.1 ± 1,116.42, respectively). It was found to be a significant prognostic marker for successful IVF treatment. Estradiol levels on down-regulated day 6 were found to be non-significant between the two groups.
Conclusions: Estradiol level on down-regulated day 2 of menstrual cycle and on the day of trigger was found to have a significant impact on the success of IVF-ET.
Keywords: Day 2; Day 6; Day of hCG trigger; Estradiol; IVF outcome.
Figures



Similar articles
-
Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.Hum Reprod. 2019 Feb 1;34(2):345-355. doi: 10.1093/humrep/dey353. Hum Reprod. 2019. PMID: 30520979
-
Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.Hum Reprod. 2020 Jun 1;35(6):1411-1420. doi: 10.1093/humrep/deaa087. Hum Reprod. 2020. PMID: 32383771 Clinical Trial.
-
Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.Hum Reprod. 2016 Aug;31(8):1859-65. doi: 10.1093/humrep/dew141. Epub 2016 Jun 14. Hum Reprod. 2016. PMID: 27301360
-
Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF.Fertil Steril. 1998 Jun;69(6):1015-9. doi: 10.1016/s0015-0282(98)00059-4. Fertil Steril. 1998. PMID: 9627286 Review.
-
Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review.Hum Reprod. 2004 Nov;19(11):2446-53. doi: 10.1093/humrep/deh473. Epub 2004 Oct 7. Hum Reprod. 2004. PMID: 15471938
Cited by
-
In Vitro Fertilization Outcomes in Donor Oocyte Cycles Compared to the Autologous Cycles in the Poseidon 4 Group of Poor Ovarian Responders.Medicina (Kaunas). 2025 Feb 10;61(2):303. doi: 10.3390/medicina61020303. Medicina (Kaunas). 2025. PMID: 40005420 Free PMC article.
-
Change of HeART: Cardiovascular Implications of Assisted Reproductive Technology.CJC Open. 2023 Sep 15;6(2Part B):142-152. doi: 10.1016/j.cjco.2023.09.008. eCollection 2024 Feb. CJC Open. 2023. PMID: 38487072 Free PMC article. Review.
-
Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility.Front Endocrinol (Lausanne). 2022 Sep 9;13:915923. doi: 10.3389/fendo.2022.915923. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36157446 Free PMC article.
-
The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.Reprod Biol Endocrinol. 2015 Oct 6;13:114. doi: 10.1186/s12958-015-0109-x. Reprod Biol Endocrinol. 2015. PMID: 26444856 Free PMC article.
-
Is the probability of pregnancy after ovarian stimulation for IVF associated with serum estradiol levels on the day of triggering final oocyte maturation with hCG? A systematic review and meta-analysis.J Assist Reprod Genet. 2020 Jul;37(7):1531-1541. doi: 10.1007/s10815-020-01829-z. Epub 2020 May 29. J Assist Reprod Genet. 2020. PMID: 32472447 Free PMC article.
References
-
- 2009 Assisted Reproductive Technology, Success Rates, National Summary and Fertility Clinic Reports. National Centers for Chronic Disease Prevention and Health Promotion, 2011.
-
- Scott RT, Toner JP, Muasher SJ, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;4:651–654. - PubMed
-
- Licciardi FL, Liu HC, Rosemwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;5:991–994. - PubMed
-
- Yanushpolsky EH, Hurwitz S, Tikh E, et al. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization in women younger than 40 years of age. Fertil Steril. 2003;1:111–115. doi: 10.1016/S0015-0282(03)00499-0. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources